Effect of wound infiltration with ropivacaine or bupivacaine analgesia in breast cancer surgery: A meta-analysis of randomized controlled trials. (October 2015)

• Record Type: Journal Article
• Authors: Tam, Ka-Wai; Chen, Shin-Yan; Huang, Tsai-Wei; Lin, Chao-Chun; Su, Chih-Ming; Li, Ching-Li; Ho, Yuan-Soon; Wang, Wan-Yu; Wu, Chih-Hsiung
• Is Part Of: International journal of surgery. Volume 22(2015)
• Page Start: 79
• Page End: 85
• Publication Date: 2015-10
• Subjects: Breast cancer -- Bupivacaine -- Local anesthesia -- Meta-analysis -- Postoperative pain -- Ropivacaine -- Wound infiltration; Surgery -- Periodicals; Surgical Procedures, Operative -- Periodicals; 617.005
• DOI: 10.1016/j.ijsu.2015.07.715
• Languages: English
• ISSNs: 1743-9191

Abstract

Abstract: Background: Although not completely painless, breast-conserving surgery is considerably less painful than modified radical mastectomy. Local anesthetics are speculated to reduce postoperative pain when placed at the surgical site. Thus, we conducted a systematic review of randomized controlled trials to evaluate the efficacy of bupivacaine or ropivacaine analgesia for pain relief in breast cancer surgery. Methods: PubMed, Embase, the Cochrane Library, Scopus, and the ClinicalTrials.gov registry were searched for studies published up to July 2015. Individual effect sizes were standardized, and a meta-analysis was performed to calculate a pooled effect size by using random effects models. Pain was assessed using a visual analog scale at 1, 2, 12, and 24 h postoperatively. The secondary outcomes included complications and analgesic consumption. Results: We reviewed 13 trials with 1150 patients. We found no difference in postoperative pain reduction at 1, 12, and 24 h after breast cancer surgery between the experimental and control groups. The severity of pain was significantly reduced in the experimental group (weighted mean difference −0.19; 95% confidence interval: −0.39–0.00) at 2 h postoperatively. Moreover, postoperative analgesic consumption did not differ significantly between the groups. No major drug-related complication was observed in any study. Conclusion: Administration of the local anesthetics bupivacaine or ropivacaine during breast cancer surgery decreased pain significantly at only 2 h but did not reduce pain at 12, and 24 h postoperatively. Highlights: Efficacy of bupivacaine or ropivacaine for pain relief in breast cancer surgery was evaluated. Analgesic consumption was not significantly different between experimental and control groups. Bupivacaine or ropivacaine infiltration caused less pain at 2 h postoperatively. No difference in postoperative pain reduction at 1, 12, and 24 h between two groups.